FLEURY S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.61 BRL | +4.28% |
|
+4.06% | -19.01% |
| Mar. 08 | Transcript : Fleury S.A., Q4 2023 Earnings Call, Mar 08, 2024 | |
| Mar. 07 | Fleury S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Good morning, everyone. I'd like to welcome al...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
2024-05-08
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
14.61
BRL
Average target price
19.9
BRL
Spread / Average Target
+36.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.01% | 1.55B | |
| -17.89% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B | |
| -15.34% | 1.03B | |
| -16.56% | 878M |
- Stock Market
- Equities
- FLRY3 Stock
- News Fleury S.A.
- Transcript : Fleury S.A., Q3 2023 Earnings Call, Nov 10, 2023
